BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mesoblast Limited 

Level 1, 843A Glenhuntly Road

Caulfield South  VIC  3162  Australia
Phone: 03-9618-7000 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Positive Spinal Disc Repair Trial Results Using Mesoblast Limited (MSB.AX) Adult Stem Cells 1/30/2014 7:02:47 AM
Mesoblast Limited (MSB.AX) Reports Positive Type 2 Diabetes Trial Results 12/4/2013 7:12:15 AM
FDA Clears Commencement of Phase 3 Chronic Heart Failure Trial Using Mesoblast Limited (MSB.AX)'s Proprietary Cells 10/31/2013 10:22:34 AM
Mesoblast Limited (MSB.AX) Updates Market on Registration Plans for GVHD Cell Product in Japan 10/28/2013 9:52:53 AM
Mesoblast Limited (MSB.AX), Intrexon Corporation and ZIOPHARM Oncology, Inc. (ZIOP.OB) to Target Cancers 10/23/2013 10:03:13 AM
Mesoblast Limited (MSB.AX) Snags Osiris Therapeutics, Inc. (OSIR)'s Stem Cell Assets for Up to $100 Million 10/11/2013 7:27:59 AM
Mesoblast Limited's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference 9/19/2013 9:41:16 AM
Mesoblast Limited's Strong Cash Position Enables Execution of Late-Stage Clinical Trials 8/29/2013 9:57:51 AM
Mesoblast Limited Receives $4.3 Million From Australian Government for Adult Stem Cell Pipeline Development 7/18/2013 9:23:17 AM
Mesoblast Limited Receives Clearance to Begin Phase 2 Clinical Trial of Mesenchymal Precursor Cells in Diabetic Nephropathy 6/26/2013 9:34:45 AM
12345678910...